National Center for Advancing Translational Sciences (NCATS)
On this page:
Mission Statement
The National Center for Advancing Translational Sciences’ (NCATS’) mission is to turn biomedical research discoveries into health solutions — including diagnostics, treatments, and interventions — through the application of translational science.
Interest Areas
General Topics
Our Extramural Scientific Divisions and Offices:
- Division of Clinical Innovation (Clinical and Translational Science Award (CTSA) Program)
- Division of Rare Diseases Research Innovation
- Office of Special Initiatives (Interdisciplinary Programs)
- Office of Strategic Alliances (Small Business Programs)
Together, they encourage bold and rigorous research approaches to build tools and technologies, support research here and beyond, train scientists, and so much more.
- Prioritize Initiatives That Address Unmet Needs
- Produce Generalizable Solutions for Common and Persistent Challenges
- Emphasize Creativity and Innovation
- Leverage Cross-Disciplinary Team Science and Boundary-Crossing Partnerships
- Enhance the Efficiency and Speed of Translational Research
Assistance Listing
Assistance listings are detailed public descriptions of federal programs used across government agencies that provide grants, loans, scholarships, insurance, and other types of assistance awards. They are maintained in the System for Award Management (SAM) and can be used to search for opportunities in Grants.gov.
View NCATS Assistance Listing Numbers
- 93.350 - National Center for Advancing Translational Sciences
Funding Opportunities and Notices
Search for NCATS’s funding opportunities and notices
- NCATS Grant Funding Opportunity Participation
- NCATS Notices in the NIH Guide for Grants and Contracts
ICO Funding Policies and Considerations
Visit NIH Fiscal Policies for NIH-wide information on appropriations and other budgetary information (salary limits, stipends, tuition/fees) and Funding Decisions to learn about NIH's consistent and unified approach for making funding decisions.
NCATS Funding Policies and Considerations builds on that general information.
Additional Information by Funding Category
Administrative Supplements
• Only in certain circumstances, NCATS may consider providing an administrative supplement to existing awards.
• PDs/PIs are strongly encouraged to consult with their NCATS Program Official (PO) to confirm eligibility, discuss the scope and justification of the proposed supplement, and obtain technical guidance.
Applications should be submitted at least 60 days prior to the anticipated need. Applications received after June 30 will generally be considered for the next fiscal year.
Applicants are strongly encouraged to discuss plans for administrative supplement applications prior to submission with the Grants Management Specialist and Program Official (PO) named on the parent grant Notice of Award.
General questions regarding administrative supplements may be directed to: [email protected].
Conferences and Meetings
NCATS supports scientific meetings, conferences and workshops within our mission of developing solutions that aid many translational research efforts (STAMTRE). Applications can be for any disease or therapeutic area, as long as the knowledge gained will be more broadly applicable to other areas of investigation. Examples include:
- Drug Repurposing
- Novel biologics technologies for better treatments of human disease
- Building multidisciplinary networks to drive science and translation
Per the Rare Diseases Act of 2002, we support scientific meetings to identify research opportunities for rare diseases. We seek applications that:
- Include the active participation of patient support groups in the planning
- Leverage recent breakthroughs or support the advancement of new research endeavors
- Establish clinical practice guidelines
Applications that buttress Clinical and Translational Science Awards (CTSA) Program goals will be considered for support by the CTSA Program.
Typically, we provide between $3,000 and $25,000 per award, but the amount of funding awarded is contingent upon availability of funds, programmatic priorities and recommendations by peer review and program staff. In general, we do not provide co-funding support in excess of the contribution made by the primary awarding NIH ICO.
Conferences starting no earlier than December 1, April 1, and July 1 will be considered for the preceding April 12, August 12, and December 12 receipt dates, respectively.
NCATS will consider the number of times a conference has been previously supported in making funding decisions.
NCATS CONFERENCE GRANTS
[email protected]
NCATS GMB NOFO
[email protected]
Small Business
NCATS supports research including, but not limited to, clinical technology, instruments, devices, and related methodologies that may have broad application to clinical research and better patient care. Our interests are in four main categories- (1) Preclinical Drug Discovery and Development; (2) Biomedical, Clinical and Health Research Informatics; (3) Clinical, Dissemination and Implementation Research and (4) Rare Diseases and Unmet Needs.
- NCATS accepts Phase IIB SBIR projects
- NCATS accepts Commercialization Readiness Pilot (CRP) projects
NCATS-SBIRSTTR
[email protected]
For technical issues E-mail OER Webmaster